激活素A介导的KAT8表达调控结核分枝杆菌感染中的铁死亡
本文研究激活素A及其下游SMAD2/3信号在结核分枝杆菌诱导的铁死亡和疾病进展中的作用。分子实验表明激活素A调控KAT8表达,KAT8介导NRF2乙酰化增强其核内可用性并增加HO-1表达。小鼠模型显示药理学抑制激活素A受体和KAT8可限制Mtb负荷、播散并改善结核病理。
要点
- 激活素A通过SMAD2/3信号调控KAT8表达,进而影响HO-1水平。
- KAT8介导NRF2乙酰化,增强其核内可用性并上调HO-1。
- 抑制激活素A受体和KAT8可限制小鼠结核分枝杆菌负荷与播散。
核心结论
- 激活素A通过SMAD2/3-KAT8-NRF2-HO-1轴调控Mtb诱导的铁死亡,抑制该通路可减轻结核病理。
研究设计与样本
- 研究采用分子实验(包括染色质免疫沉淀和功能缺失分析)及结核小鼠体内模型。
主要发现
- 结核患者中激活素A上调且水平与疾病严重程度相关。
- Mtb感染诱导铁死亡,激活素A通过SMAD2/3信号调控KAT8表达。
- KAT8介导Mtb感染时NRF2乙酰化,增强其核内可用性并增加HO-1表达。
- 小鼠模型中药理学抑制激活素A受体和KAT8可限制Mtb负荷、减少播散并改善结核病理。
临床怎么用
- 靶向激活素A受体和KAT8可能成为限制结核分枝杆菌负荷与播散的潜在策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Activin A, a secretory glycoprotein, is up-regulated in patients with tuberculosis, and its levels are correlated with disease severity. During infection, Mycobacterium tuberculosis (Mtb) induces ferroptosis, an iron-induced mode of cell death, that aids in dissemination and survival. Here, we identify a functional role for activin A and the downstream mothers against decapentaplegic homolog (SMAD) 2/3 signaling in Mtb-induced ferroptosis and disease progression. Molecular assays, including chromatin immunoprecipitation and loss-of-function analysis, demonstrated that activin A regulates the expression of KAT8, which in turn regulates levels of heme oxygenase (HO-1). Mechanistically, we identify that KAT8-mediated acetylation of nuclear factor erythroid 2-related factor (NRF2) during Mtb infection enhances its nuclear availability leading to increased HO-1 expression. Finally, using an in vivo mouse model of tuberculosis, we show that the pharmacological inhibition of activin A receptor and KAT8 restricts Mtb burden, limits dissemination and ameliorates tuberculosis pathology. Thus, we report a novel role for activin A in regulating NRF2 localization and outline its potential consequences during tuberculosis.
引用
- Satish BA, Sundar S, Rajmani RS, et al. Role of Activin A-Mediated KAT8 Expression in Regulating Ferroptosis During Mycobacterium tuberculosis Infection. J Infect Dis. 2026. PMID: 40976643. doi:10.1093/infdis/jiaf482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。